https://zosuquidarmodulator.co....m/bioavailable-track
The research, though valuable, faces constraints, notably the lack of long-term follow-up, the variability in low-rTMS application sites, and the differing stimulation frequencies (0.5 or 1 Hz). For future validation of low-rTMS combined therapy's efficacy for post-stroke depression, the utilization of randomized controlled trials must include a larger participant pool and a longer duration of observation. Meanwhile, a meta-an
Like
Comment
Share
